{
  "count": 127,
  "pages": [
    {
      "slug": "about",
      "title": "About Amino Desk",
      "description": "Who Amino Desk is, what it covers, how it makes money and what it will not do.",
      "url": "https://aminodesk.com/about",
      "markdown_url": "https://aminodesk.com/about.md",
      "kind": "site",
      "updated": "2026-11-14"
    },
    {
      "slug": "affiliate-disclosure",
      "title": "Affiliate disclosure",
      "description": "How Amino Desk earns money from provider links, which providers qualify, and how paid links are labeled.",
      "url": "https://aminodesk.com/affiliate-disclosure",
      "markdown_url": "https://aminodesk.com/affiliate-disclosure.md",
      "kind": "site",
      "updated": "2026-11-17"
    },
    {
      "slug": "ai",
      "title": "How we use AI",
      "description": "Where Amino Desk uses AI tools in research, writing and video, and where a person makes the call.",
      "url": "https://aminodesk.com/ai",
      "markdown_url": "https://aminodesk.com/ai.md",
      "kind": "site",
      "updated": "2026-11-14"
    },
    {
      "slug": "calculator",
      "title": "Peptide reconstitution calculator",
      "description": "Free peptide reconstitution calculator: enter vial size, water added and your prescribed dose to get insulin syringe units, mL and doses per vial.",
      "url": "https://aminodesk.com/calculator",
      "markdown_url": "https://aminodesk.com/calculator.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "compare",
      "title": "Compare peptides side by side",
      "description": "Pick two to four peptides or GLP-1s and compare evidence grade, legal status, uses and a one-line summary side by side.",
      "url": "https://aminodesk.com/compare",
      "markdown_url": "https://aminodesk.com/compare.md",
      "kind": "site",
      "updated": "2026-11-17"
    },
    {
      "slug": "compare/bpc-157-vs-tb-500",
      "title": "BPC-157 vs TB-500",
      "description": "BPC-157 and TB-500 compared: what each is, how much human evidence exists, legal forms under the 2026 policy, and reported dosing.",
      "url": "https://aminodesk.com/compare/bpc-157-vs-tb-500",
      "markdown_url": "https://aminodesk.com/compare/bpc-157-vs-tb-500.md",
      "kind": "health",
      "updated": "2026-11-14"
    },
    {
      "slug": "compare/semaglutide-vs-tirzepatide",
      "title": "Semaglutide vs tirzepatide",
      "description": "Wegovy vs Zepbound compared: the head-to-head trial result, pill vs injection, heart outcomes, approved uses and current cash prices.",
      "url": "https://aminodesk.com/compare/semaglutide-vs-tirzepatide",
      "markdown_url": "https://aminodesk.com/compare/semaglutide-vs-tirzepatide.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "costs",
      "title": "What it costs",
      "description": "GLP-1 and peptide pricing in November 2026: manufacturer-direct cash prices by dose, compounded ranges, and how teaser pricing works.",
      "url": "https://aminodesk.com/costs",
      "markdown_url": "https://aminodesk.com/costs.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "developers",
      "title": "API and AI access",
      "description": "Amino Desk for AI assistants and developers: Markdown pages, a free JSON API and an MCP server for our evidence-graded peptide and GLP-1 reference.",
      "url": "https://aminodesk.com/developers",
      "markdown_url": "https://aminodesk.com/developers.md",
      "kind": "site",
      "updated": "2026-11-17"
    },
    {
      "slug": "disclaimers",
      "title": "Disclaimers",
      "description": "What Amino Desk is and is not: general information, not medical advice, how dosing information should be read, and what to do in an emergency.",
      "url": "https://aminodesk.com/disclaimers",
      "markdown_url": "https://aminodesk.com/disclaimers.md",
      "kind": "site",
      "updated": "2026-11-14"
    },
    {
      "slug": "editorial-policy",
      "title": "Editorial policy",
      "description": "How Amino Desk sources, grades evidence, reports dosing, handles corrections and separates editorial from revenue.",
      "url": "https://aminodesk.com/editorial-policy",
      "markdown_url": "https://aminodesk.com/editorial-policy.md",
      "kind": "site",
      "updated": "2026-11-14"
    },
    {
      "slug": "finder",
      "title": "Find a compound",
      "description": "Filter peptides and GLP-1s by what you are trying to do and by whether there is a lawful way to get them, with an evidence grade on every result.",
      "url": "https://aminodesk.com/finder",
      "markdown_url": "https://aminodesk.com/finder.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "glp1-log",
      "title": "Medication log: doses, weight and progress",
      "description": "A free, private log for a GLP-1 or peptide routine: schedule, doses, step-ups, planned breaks, injection sites, weight, protein and side effects, saved on your own device. No account.",
      "url": "https://aminodesk.com/glp1-log",
      "markdown_url": "https://aminodesk.com/glp1-log.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "goals",
      "title": "Peptides by goal",
      "description": "Peptides and GLP-1s by goal: weight loss, muscle, injury recovery, skin, focus, sleep, energy, sexual health and hormones, with evidence and legal status.",
      "url": "https://aminodesk.com/goals",
      "markdown_url": "https://aminodesk.com/goals.md",
      "kind": "site",
      "updated": "2026-11-17"
    },
    {
      "slug": "goals/energy-and-longevity",
      "title": "Peptides for energy and longevity",
      "description": "NAD+, MOTS-c, Epitalon, SS-31 and others sold for energy and aging: what has been tested in people and what you can legally get.",
      "url": "https://aminodesk.com/goals/energy-and-longevity",
      "markdown_url": "https://aminodesk.com/goals/energy-and-longevity.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "goals/focus-and-mood",
      "title": "Peptides for focus and mood",
      "description": "Semax, Selank, dihexa, methylene blue and others sold for cognition and anxiety: evidence, legal status and the drug interaction to know.",
      "url": "https://aminodesk.com/goals/focus-and-mood",
      "markdown_url": "https://aminodesk.com/goals/focus-and-mood.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "goals/hormones-and-fertility",
      "title": "Peptides for hormones and fertility",
      "description": "HCG and kisspeptin: what each is approved or studied for in fertility and testosterone care.",
      "url": "https://aminodesk.com/goals/hormones-and-fertility",
      "markdown_url": "https://aminodesk.com/goals/hormones-and-fertility.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "goals/injury-recovery",
      "title": "Peptides for injury and tissue repair",
      "description": "BPC-157, TB-500, KPV and others sold for healing: what the human evidence shows and what the October 2026 policy changed.",
      "url": "https://aminodesk.com/goals/injury-recovery",
      "markdown_url": "https://aminodesk.com/goals/injury-recovery.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "goals/muscle-and-growth-hormone",
      "title": "Peptides for muscle and growth hormone",
      "description": "Sermorelin, ipamorelin, CJC-1295, tesamorelin and growth hormone compared by evidence and legal status. What raises growth hormone and what that has been shown to do.",
      "url": "https://aminodesk.com/goals/muscle-and-growth-hormone",
      "markdown_url": "https://aminodesk.com/goals/muscle-and-growth-hormone.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "goals/sexual-health",
      "title": "Peptides for sexual health",
      "description": "PT-141 (Vyleesi), kisspeptin, Melanotan II and HCG: which is FDA-approved, for whom, and what the trials measured.",
      "url": "https://aminodesk.com/goals/sexual-health",
      "markdown_url": "https://aminodesk.com/goals/sexual-health.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "goals/skin-and-hair",
      "title": "Peptides for skin and hair",
      "description": "GHK-Cu, glutathione and the melanotans: which have human evidence for skin, which are creams versus injections, and the safety problems to know about.",
      "url": "https://aminodesk.com/goals/skin-and-hair",
      "markdown_url": "https://aminodesk.com/goals/skin-and-hair.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "goals/sleep",
      "title": "Peptides for sleep",
      "description": "DSIP, sermorelin and Epitalon are sold for sleep. What the evidence shows, and why DSIP was the one peptide an FDA committee voted down in 2026.",
      "url": "https://aminodesk.com/goals/sleep",
      "markdown_url": "https://aminodesk.com/goals/sleep.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "goals/weight-loss",
      "title": "Peptides for weight loss: what works and what is legal",
      "description": "Which weight-loss peptides have real evidence, which are still experimental, and which you can legally get. Semaglutide, tirzepatide, retatrutide and more.",
      "url": "https://aminodesk.com/goals/weight-loss",
      "markdown_url": "https://aminodesk.com/goals/weight-loss.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "guides",
      "title": "Guides and tools",
      "description": "Amino Desk guides: reconstitution calculator, mixing and injection, supplies, protein on GLP-1 medications, and seller code names.",
      "url": "https://aminodesk.com/guides",
      "markdown_url": "https://aminodesk.com/guides.md",
      "kind": "site",
      "updated": "2026-11-17"
    },
    {
      "slug": "guides/mixing-and-injecting",
      "title": "How to mix and inject a peptide safely",
      "description": "Step-by-step guide to reconstituting a prescription peptide vial, drawing a dose, injecting under the skin, storage and needle disposal, with CDC, FDA and label sources.",
      "url": "https://aminodesk.com/guides/mixing-and-injecting",
      "markdown_url": "https://aminodesk.com/guides/mixing-and-injecting.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "guides/protein-on-glp-1",
      "title": "Protein and muscle on GLP-1 medications",
      "description": "How much of the weight lost on semaglutide and tirzepatide is muscle, and the protein and strength-training targets from the 2025 joint medical society advisory.",
      "url": "https://aminodesk.com/guides/protein-on-glp-1",
      "markdown_url": "https://aminodesk.com/guides/protein-on-glp-1.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "guides/seller-code-names",
      "title": "GLP-3, GLP1-R, reta: what seller code names mean",
      "description": "GLP-3 is not a real hormone. What codes like GLP-3, GLP1-R, GLP1-T and reta refer to, why sellers use them, and what FDA warning letters say.",
      "url": "https://aminodesk.com/guides/seller-code-names",
      "markdown_url": "https://aminodesk.com/guides/seller-code-names.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "guides/supplies",
      "title": "Syringes, needles and supplies: a plain guide",
      "description": "Insulin syringe sizes and markings, needle gauge and length, alcohol pads and sharps containers explained for people with a prescription vial.",
      "url": "https://aminodesk.com/guides/supplies",
      "markdown_url": "https://aminodesk.com/guides/supplies.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "home",
      "title": "Amino Desk",
      "description": "Amino Desk is an independent guide to peptides and GLP-1 medications: what is legal, what the evidence shows, what it costs.",
      "url": "https://aminodesk.com/",
      "markdown_url": "https://aminodesk.com/index.md",
      "kind": "site",
      "updated": "2026-11-17"
    },
    {
      "slug": "library",
      "title": "Peptide library",
      "description": "The peptides and related compounds people ask about most: what each is, its legal lane, and how it is accessed.",
      "url": "https://aminodesk.com/library",
      "markdown_url": "https://aminodesk.com/library.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/5-amino-1mq",
      "title": "5-amino-1MQ",
      "description": "5-amino-1MQ explained: an NNMT-inhibiting small molecule with striking mouse data, zero human trials, and a 40-fold spread in the doses people use.",
      "url": "https://aminodesk.com/library/5-amino-1mq",
      "markdown_url": "https://aminodesk.com/library/5-amino-1mq.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/adamax",
      "title": "Adamax",
      "description": "Adamax explained: a Semax derivative with an adamantane group, why its claims are extrapolated from Semax, and its legal status.",
      "url": "https://aminodesk.com/library/adamax",
      "markdown_url": "https://aminodesk.com/library/adamax.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/adipotide",
      "title": "Adipotide",
      "description": "Adipotide explained: a fat-targeting peptide that caused kidney damage in every treated primate, which is why it never reached human trials.",
      "url": "https://aminodesk.com/library/adipotide",
      "markdown_url": "https://aminodesk.com/library/adipotide.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/ahk-cu",
      "title": "AHK-Cu (copper tripeptide)",
      "description": "AHK-Cu explained: a copper peptide sold for hair growth, the single 2007 laboratory study behind it, and how it compares with GHK-Cu.",
      "url": "https://aminodesk.com/library/ahk-cu",
      "markdown_url": "https://aminodesk.com/library/ahk-cu.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/aod-9604",
      "title": "AOD-9604",
      "description": "AOD-9604 explained: the growth hormone fragment whose large human obesity trial failed to beat placebo, its safety record and its compounding status.",
      "url": "https://aminodesk.com/library/aod-9604",
      "markdown_url": "https://aminodesk.com/library/aod-9604.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/ara-290",
      "title": "ARA-290 (cibinetide)",
      "description": "ARA-290 explained: a peptide derived from erythropoietin, its small trials in nerve pain from sarcoidosis, and why development stopped before Phase 3.",
      "url": "https://aminodesk.com/library/ara-290",
      "markdown_url": "https://aminodesk.com/library/ara-290.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/bpc-157",
      "title": "BPC-157",
      "description": "BPC-157 explained: what it is, how little human research exists, its legal status after the October 2026 HHS policy, the doses people report and where they come from.",
      "url": "https://aminodesk.com/library/bpc-157",
      "markdown_url": "https://aminodesk.com/library/bpc-157.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/bpc-157-kpv",
      "title": "BPC-157 + KPV blend",
      "description": "BPC-157 + KPV blend explained: what is in the blend, why no trial has tested it, and its legal position in the US.",
      "url": "https://aminodesk.com/library/bpc-157-kpv",
      "markdown_url": "https://aminodesk.com/library/bpc-157-kpv.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/cagrilintide",
      "title": "Cagrilintide (and CagriSema)",
      "description": "Cagrilintide explained: Novo Nordisk's amylin drug, the CagriSema trial results with semaglutide, its FDA review, and why it cannot be compounded.",
      "url": "https://aminodesk.com/library/cagrilintide",
      "markdown_url": "https://aminodesk.com/library/cagrilintide.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/cagrisema",
      "title": "CagriSema (cagrilintide + semaglutide)",
      "description": "CagriSema explained: Novo Nordisk's weekly combination of cagrilintide and semaglutide, its Phase 3 results, and where the FDA review stood in November 2026.",
      "url": "https://aminodesk.com/library/cagrisema",
      "markdown_url": "https://aminodesk.com/library/cagrisema.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/cartalax",
      "title": "Cartalax",
      "description": "Cartalax explained: a Russian short peptide sold for cartilage and joint support, what evidence exists, and why it has no lawful route in the US.",
      "url": "https://aminodesk.com/library/cartalax",
      "markdown_url": "https://aminodesk.com/library/cartalax.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/cerebrolysin",
      "title": "Cerebrolysin",
      "description": "Cerebrolysin explained: a pig-brain peptide mixture approved in over 50 countries for stroke and dementia, what Cochrane reviews found, and its status in the US.",
      "url": "https://aminodesk.com/library/cerebrolysin",
      "markdown_url": "https://aminodesk.com/library/cerebrolysin.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/cjc-1295",
      "title": "CJC-1295",
      "description": "CJC-1295 explained: the long-acting growth-hormone-releasing peptide, what its one human trial program showed, legal status and study doses.",
      "url": "https://aminodesk.com/library/cjc-1295",
      "markdown_url": "https://aminodesk.com/library/cjc-1295.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/cjc-1295-ipamorelin",
      "title": "CJC-1295 + ipamorelin blend",
      "description": "The CJC-1295 and ipamorelin blend explained: what each part does, why no trial has tested the pair, and why neither peptide can be legally compounded in the US.",
      "url": "https://aminodesk.com/library/cjc-1295-ipamorelin",
      "markdown_url": "https://aminodesk.com/library/cjc-1295-ipamorelin.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/cjc-1295-ipamorelin-tesamorelin",
      "title": "CJC-1295 + ipamorelin + tesamorelin blend",
      "description": "CJC-1295 + ipamorelin + tesamorelin blend explained: what is in the blend, why no trial has tested it, and its legal position in the US.",
      "url": "https://aminodesk.com/library/cjc-1295-ipamorelin-tesamorelin",
      "markdown_url": "https://aminodesk.com/library/cjc-1295-ipamorelin-tesamorelin.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/cortagen",
      "title": "Cortagen",
      "description": "Cortagen explained: a Russian short peptide sold for brain and nerve support, what evidence exists, and why it has no lawful route in the US.",
      "url": "https://aminodesk.com/library/cortagen",
      "markdown_url": "https://aminodesk.com/library/cortagen.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/dihexa",
      "title": "Dihexa",
      "description": "Dihexa explained: a cognition peptide with no human data at all and a retracted mechanism paper, sold as a research chemical.",
      "url": "https://aminodesk.com/library/dihexa",
      "markdown_url": "https://aminodesk.com/library/dihexa.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/dsip",
      "title": "DSIP (delta sleep-inducing peptide)",
      "description": "DSIP explained: a sleep peptide the FDA advisory committee voted against in July 2026, with no established dose and thin human evidence.",
      "url": "https://aminodesk.com/library/dsip",
      "markdown_url": "https://aminodesk.com/library/dsip.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/dulaglutide",
      "title": "Dulaglutide (Trulicity)",
      "description": "Dulaglutide explained: the weekly GLP-1 sold as Trulicity for type 2 diabetes, why it is not a weight-loss drug, its label dose steps, trial weight figures and boxed warning.",
      "url": "https://aminodesk.com/library/dulaglutide",
      "markdown_url": "https://aminodesk.com/library/dulaglutide.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/eloralintide",
      "title": "Eloralintide",
      "description": "Eloralintide explained: Lilly's weekly amylin drug for obesity, its Phase 2 weight-loss results, where the Phase 3 program stands, and why it cannot be prescribed.",
      "url": "https://aminodesk.com/library/eloralintide",
      "markdown_url": "https://aminodesk.com/library/eloralintide.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/epitalon",
      "title": "Epitalon",
      "description": "Epitalon explained: a four-amino-acid peptide promoted for longevity and sleep, what the cell and human studies show, and its legal status.",
      "url": "https://aminodesk.com/library/epitalon",
      "markdown_url": "https://aminodesk.com/library/epitalon.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/epitalon-mots-c",
      "title": "Epitalon + MOTS-c blend",
      "description": "Epitalon + MOTS-c blend explained: what is in the blend, why no trial has tested it, and its legal position in the US.",
      "url": "https://aminodesk.com/library/epitalon-mots-c",
      "markdown_url": "https://aminodesk.com/library/epitalon-mots-c.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/fgl",
      "title": "FGL (FG loop peptide)",
      "description": "FGL explained: a peptide modeled on a nerve cell adhesion molecule, its rat memory data, the one human safety study, and its legal status.",
      "url": "https://aminodesk.com/library/fgl",
      "markdown_url": "https://aminodesk.com/library/fgl.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/foxo4-dri",
      "title": "FOXO4-DRI",
      "description": "FOXO4-DRI explained: a senolytic peptide with a striking 2017 mouse study, no human trials, and why its target, p53, calls for caution.",
      "url": "https://aminodesk.com/library/foxo4-dri",
      "markdown_url": "https://aminodesk.com/library/foxo4-dri.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/ghk-cu",
      "title": "GHK-Cu and the Glow stack",
      "description": "GHK-Cu explained: the copper peptide in skincare, why the injectable form is a different matter, its FDA status, and what the Glow stack is.",
      "url": "https://aminodesk.com/library/ghk-cu",
      "markdown_url": "https://aminodesk.com/library/ghk-cu.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/ghk-cu-bpc-157",
      "title": "GHK-Cu + BPC-157 blend",
      "description": "GHK-Cu + BPC-157 blend explained: what is in the blend, why no trial has tested it, and its legal position in the US.",
      "url": "https://aminodesk.com/library/ghk-cu-bpc-157",
      "markdown_url": "https://aminodesk.com/library/ghk-cu-bpc-157.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/ghk-cu-kpv",
      "title": "GHK-Cu + KPV blend",
      "description": "GHK-Cu + KPV blend explained: what is in the blend, why no trial has tested it, and its legal position in the US.",
      "url": "https://aminodesk.com/library/ghk-cu-kpv",
      "markdown_url": "https://aminodesk.com/library/ghk-cu-kpv.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/ghrp-2-ghrp-6",
      "title": "GHRP-2 and GHRP-6",
      "description": "GHRP-2 and GHRP-6 explained: older growth-hormone-releasing peptides that also raise cortisol, prolactin and appetite. Evidence, status and reported doses.",
      "url": "https://aminodesk.com/library/ghrp-2-ghrp-6",
      "markdown_url": "https://aminodesk.com/library/ghrp-2-ghrp-6.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/glow-blend",
      "title": "GLOW blend (GHK-Cu + BPC-157 + TB-500)",
      "description": "The GLOW blend explained: GHK-Cu, BPC-157 and TB-500 in one vial, what it is sold for, why it falls outside the 2026 compounding policy, and the lack of human trials.",
      "url": "https://aminodesk.com/library/glow-blend",
      "markdown_url": "https://aminodesk.com/library/glow-blend.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/glutathione",
      "title": "Glutathione (injectable)",
      "description": "Injectable glutathione explained: the antioxidant sold in IV drips for skin and wellness, FDA alerts over contaminated compounded batches, and the evidence.",
      "url": "https://aminodesk.com/library/glutathione",
      "markdown_url": "https://aminodesk.com/library/glutathione.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/gonadorelin",
      "title": "Gonadorelin",
      "description": "Gonadorelin explained: synthetic GnRH, why no FDA-approved product is sold in the US today, the evidence for pump therapy, and the thin evidence for its use alongside testosterone.",
      "url": "https://aminodesk.com/library/gonadorelin",
      "markdown_url": "https://aminodesk.com/library/gonadorelin.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/growth-hormone",
      "title": "Growth hormone (HGH)",
      "description": "Human growth hormone explained: what somatropin is approved for, why anti-aging and bodybuilding use is restricted by federal law, dosing and side effects.",
      "url": "https://aminodesk.com/library/growth-hormone",
      "markdown_url": "https://aminodesk.com/library/growth-hormone.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/hcg",
      "title": "HCG",
      "description": "HCG explained: what human chorionic gonadotropin is approved for, how it is used alongside testosterone therapy, reported dosing, and why it is not a weight-loss drug.",
      "url": "https://aminodesk.com/library/hcg",
      "markdown_url": "https://aminodesk.com/library/hcg.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/hexarelin",
      "title": "Hexarelin",
      "description": "Hexarelin explained: a growth hormone releasing peptide whose effect fades with repeated use, what the short human studies show, and why it has no lawful route in the US.",
      "url": "https://aminodesk.com/library/hexarelin",
      "markdown_url": "https://aminodesk.com/library/hexarelin.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/humanin",
      "title": "Humanin",
      "description": "Humanin explained: a peptide made by mitochondria, what observational human studies show, and why injecting it has no trial behind it.",
      "url": "https://aminodesk.com/library/humanin",
      "markdown_url": "https://aminodesk.com/library/humanin.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/igf-1-lr3",
      "title": "IGF-1 LR3",
      "description": "IGF-1 LR3 explained: a research reagent with no human trials, and what the approved IGF-1 drug's label shows about the risks of this hormone.",
      "url": "https://aminodesk.com/library/igf-1-lr3",
      "markdown_url": "https://aminodesk.com/library/igf-1-lr3.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/ipamorelin",
      "title": "Ipamorelin",
      "description": "Ipamorelin explained: a growth hormone secretagogue with one failed human trial, its unsettled legal status, and where reported doses come from.",
      "url": "https://aminodesk.com/library/ipamorelin",
      "markdown_url": "https://aminodesk.com/library/ipamorelin.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/khavinson-bioregulators",
      "title": "Khavinson short peptides: Bronchogen, Cardiogen and seven more",
      "description": "Nine Russian organ-specific bioregulator peptides explained, including Bronchogen, Cardiogen, Livagen and Testagen: the evidence, legal status and why no dose is given.",
      "url": "https://aminodesk.com/library/khavinson-bioregulators",
      "markdown_url": "https://aminodesk.com/library/khavinson-bioregulators.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/kisspeptin",
      "title": "Kisspeptin",
      "description": "Kisspeptin explained: a reproductive hormone with real controlled trials behind it, why the sold form differs from the studied one, and its investigational status.",
      "url": "https://aminodesk.com/library/kisspeptin",
      "markdown_url": "https://aminodesk.com/library/kisspeptin.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/klow-blend",
      "title": "KLOW blend (GHK-Cu + BPC-157 + TB-500 + KPV)",
      "description": "The KLOW blend explained: four peptides in a fixed 50/10/10/10 vial, why you cannot adjust one ingredient, its legal position under the 2026 policy and the lack of trials.",
      "url": "https://aminodesk.com/library/klow-blend",
      "markdown_url": "https://aminodesk.com/library/klow-blend.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/kpv",
      "title": "KPV",
      "description": "KPV explained: a three-amino-acid peptide promoted for gut and skin inflammation, with no human efficacy trials and no established dose.",
      "url": "https://aminodesk.com/library/kpv",
      "markdown_url": "https://aminodesk.com/library/kpv.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/l-carnitine",
      "title": "L-carnitine (injectable)",
      "description": "L-carnitine explained: approved for carnitine deficiency, sold as weight-loss shots. What the trials show, label dosing, and the risks of injecting it.",
      "url": "https://aminodesk.com/library/l-carnitine",
      "markdown_url": "https://aminodesk.com/library/l-carnitine.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/larazotide",
      "title": "Larazotide",
      "description": "Larazotide explained: an oral peptide tested for celiac disease, the Phase 3 trial that was stopped in 2022, and why it has no lawful route in the US.",
      "url": "https://aminodesk.com/library/larazotide",
      "markdown_url": "https://aminodesk.com/library/larazotide.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/lipo-c",
      "title": "Lipo-C and Lipo-C + B12 (MIC lipotropic injections)",
      "description": "Lipo-C explained: a compounded shot of methionine, inositol and choline sold for fat loss, what is in it, and why no trial supports the weight-loss claim.",
      "url": "https://aminodesk.com/library/lipo-c",
      "markdown_url": "https://aminodesk.com/library/lipo-c.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/liraglutide",
      "title": "Liraglutide (Saxenda, Victoza)",
      "description": "Liraglutide explained: the daily GLP-1 injection sold as Saxenda and Victoza, its trial results, the label dose schedule, the boxed warning and the first generic for weight loss.",
      "url": "https://aminodesk.com/library/liraglutide",
      "markdown_url": "https://aminodesk.com/library/liraglutide.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/ll-37",
      "title": "LL-37 (cathelicidin)",
      "description": "LL-37 explained: the human antimicrobial peptide, its wound-healing trials as a topical treatment, and its pending FDA compounding review.",
      "url": "https://aminodesk.com/library/ll-37",
      "markdown_url": "https://aminodesk.com/library/ll-37.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/mazdutide",
      "title": "Mazdutide",
      "description": "Mazdutide explained: a weekly weight-loss injection approved in China, its trial results and dosing, and its status in the United States.",
      "url": "https://aminodesk.com/library/mazdutide",
      "markdown_url": "https://aminodesk.com/library/mazdutide.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/melanotan-i",
      "title": "Melanotan I (afamelanotide, Scenesse)",
      "description": "Melanotan I explained: the approved form is a clinic-inserted implant for a rare light-sensitivity disorder, not a tanning injection. Label dosing and warnings.",
      "url": "https://aminodesk.com/library/melanotan-i",
      "markdown_url": "https://aminodesk.com/library/melanotan-i.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/melanotan-ii",
      "title": "Melanotan II",
      "description": "Melanotan II explained: the unapproved tanning peptide, what small studies showed, the melanoma and mole reports, and its legal status.",
      "url": "https://aminodesk.com/library/melanotan-ii",
      "markdown_url": "https://aminodesk.com/library/melanotan-ii.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/methylene-blue",
      "title": "Methylene blue",
      "description": "Methylene blue explained: an FDA-approved prescription drug with a boxed warning, now sold as a nootropic. What the evidence supports and the interaction that matters.",
      "url": "https://aminodesk.com/library/methylene-blue",
      "markdown_url": "https://aminodesk.com/library/methylene-blue.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/mk-677",
      "title": "MK-677 (ibutamoren)",
      "description": "MK-677 explained: an oral growth hormone booster that is not a peptide, what its human trials found, the heart failure signal that stopped one trial, and its legal status.",
      "url": "https://aminodesk.com/library/mk-677",
      "markdown_url": "https://aminodesk.com/library/mk-677.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/mots-c",
      "title": "MOTS-c",
      "description": "MOTS-c explained: a mitochondrial peptide promoted for metabolism and longevity, with no completed human studies of the drug itself.",
      "url": "https://aminodesk.com/library/mots-c",
      "markdown_url": "https://aminodesk.com/library/mots-c.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/n-acetyl-selank",
      "title": "N-acetyl Selank amidate",
      "description": "N-acetyl Selank amidate explained: a chemically capped version of Selank, why Selank studies do not transfer to it, and its legal status.",
      "url": "https://aminodesk.com/library/n-acetyl-selank",
      "markdown_url": "https://aminodesk.com/library/n-acetyl-selank.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/n-acetyl-semax",
      "title": "N-acetyl Semax amidate",
      "description": "N-acetyl Semax amidate explained: a chemically capped version of Semax, why Semax studies do not transfer to it, and its legal status.",
      "url": "https://aminodesk.com/library/n-acetyl-semax",
      "markdown_url": "https://aminodesk.com/library/n-acetyl-semax.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/nad",
      "title": "NAD+",
      "description": "NAD+ injections explained: what NAD+ is, why the human evidence is for oral supplements and not injections, legal status and cost.",
      "url": "https://aminodesk.com/library/nad",
      "markdown_url": "https://aminodesk.com/library/nad.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/oxytocin",
      "title": "Oxytocin",
      "description": "Oxytocin explained: approved as a hospital drug for labor, not approved as a nasal spray, and what the largest trial of the nasal form found.",
      "url": "https://aminodesk.com/library/oxytocin",
      "markdown_url": "https://aminodesk.com/library/oxytocin.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/p21",
      "title": "P21 (P021)",
      "description": "P21 (P021) explained: a nerve growth factor fragment with mouse data on memory, no human trials, and one failed independent replication.",
      "url": "https://aminodesk.com/library/p21",
      "markdown_url": "https://aminodesk.com/library/p21.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/pe-22-28",
      "title": "PE-22-28",
      "description": "PE-22-28 explained: a spadin-derived peptide that blocks the TREK-1 channel, its rodent antidepressant data, and the absence of human trials.",
      "url": "https://aminodesk.com/library/pe-22-28",
      "markdown_url": "https://aminodesk.com/library/pe-22-28.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/peg-mgf",
      "title": "PEG-MGF (mechano growth factor)",
      "description": "PEG-MGF explained: a modified muscle growth factor with no human trials, why no protocol is published here, and its legal and anti-doping status.",
      "url": "https://aminodesk.com/library/peg-mgf",
      "markdown_url": "https://aminodesk.com/library/peg-mgf.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/pentosan-polysulfate",
      "title": "Pentosan polysulfate (Elmiron)",
      "description": "Pentosan polysulfate explained: an approved capsule for bladder pain, the label dose, the eye warning that came with long-term use, and the unapproved injections sold for joints.",
      "url": "https://aminodesk.com/library/pentosan-polysulfate",
      "markdown_url": "https://aminodesk.com/library/pentosan-polysulfate.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/pinealon",
      "title": "Pinealon",
      "description": "Pinealon explained: a three-amino-acid Russian 'bioregulator' peptide sold for brain health, with no controlled human trials and no legal US route.",
      "url": "https://aminodesk.com/library/pinealon",
      "markdown_url": "https://aminodesk.com/library/pinealon.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/pnc-27",
      "title": "PNC-27",
      "description": "PNC-27 explained: a peptide sold online as a cancer cure, the FDA warning against it, and the contamination the agency found.",
      "url": "https://aminodesk.com/library/pnc-27",
      "markdown_url": "https://aminodesk.com/library/pnc-27.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/progesterone",
      "title": "Progesterone",
      "description": "Progesterone explained: a hormone, not a peptide, what the capsules are approved for, the label doses, the boxed warning that applies with estrogen, and the peanut oil caution.",
      "url": "https://aminodesk.com/library/progesterone",
      "markdown_url": "https://aminodesk.com/library/progesterone.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/pt-141",
      "title": "PT-141 (bremelanotide, Vyleesi)",
      "description": "PT-141 explained: the FDA-approved libido injection for premenopausal women, its label dosing, blood pressure and skin-darkening warnings, and the vials sold online.",
      "url": "https://aminodesk.com/library/pt-141",
      "markdown_url": "https://aminodesk.com/library/pt-141.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/pt-141-oxytocin",
      "title": "PT-141 + oxytocin blend",
      "description": "PT-141 + oxytocin blend explained: what is in the blend, why no trial has tested it, and its legal position in the US.",
      "url": "https://aminodesk.com/library/pt-141-oxytocin",
      "markdown_url": "https://aminodesk.com/library/pt-141-oxytocin.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/rapamycin",
      "title": "Rapamycin (sirolimus)",
      "description": "Rapamycin explained: an approved transplant drug taken off-label for longevity, what the PEARL trial found, the boxed warning, and why the human aging question is still open.",
      "url": "https://aminodesk.com/library/rapamycin",
      "markdown_url": "https://aminodesk.com/library/rapamycin.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/retatrutide",
      "title": "Retatrutide",
      "description": "Retatrutide explained: Phase 3 weight-loss results, the dose schedule used in trials, side effects, and why it cannot be legally bought yet.",
      "url": "https://aminodesk.com/library/retatrutide",
      "markdown_url": "https://aminodesk.com/library/retatrutide.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/retatrutide-cagrilintide",
      "title": "Retatrutide + cagrilintide blend",
      "description": "Retatrutide + cagrilintide blend explained: what is in the blend, why no trial has tested it, and its legal position in the US.",
      "url": "https://aminodesk.com/library/retatrutide-cagrilintide",
      "markdown_url": "https://aminodesk.com/library/retatrutide-cagrilintide.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/selank",
      "title": "Selank",
      "description": "Selank explained: a Russian anti-anxiety peptide with small trials behind it, no FDA approval, and no US compounding route.",
      "url": "https://aminodesk.com/library/selank",
      "markdown_url": "https://aminodesk.com/library/selank.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/semaglutide",
      "title": "Semaglutide (Wegovy, Ozempic)",
      "description": "Semaglutide explained: what it is, what trials found, the FDA label dosing schedule for the injection and the pill, side effects and self-pay cost.",
      "url": "https://aminodesk.com/library/semaglutide",
      "markdown_url": "https://aminodesk.com/library/semaglutide.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/semax",
      "title": "Semax",
      "description": "Semax explained: a nasal peptide approved in Russia for stroke care, its evidence, US legal status, and the doses reported in Russian practice.",
      "url": "https://aminodesk.com/library/semax",
      "markdown_url": "https://aminodesk.com/library/semax.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/semax-selank",
      "title": "Semax + Selank blend",
      "description": "Semax + Selank blend explained: what is in the blend, why no trial has tested it, and its legal position in the US.",
      "url": "https://aminodesk.com/library/semax-selank",
      "markdown_url": "https://aminodesk.com/library/semax-selank.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/sermorelin",
      "title": "Sermorelin",
      "description": "Sermorelin explained: a growth-hormone-releasing peptide that was once FDA-approved, how it is prescribed today, reported adult dosing and cost.",
      "url": "https://aminodesk.com/library/sermorelin",
      "markdown_url": "https://aminodesk.com/library/sermorelin.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/slu-pp-332",
      "title": "SLU-PP-332",
      "description": "SLU-PP-332 explained: the 'exercise pill' ERR agonist, what the mouse data actually showed, and why there is no human dose.",
      "url": "https://aminodesk.com/library/slu-pp-332",
      "markdown_url": "https://aminodesk.com/library/slu-pp-332.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/snap-8",
      "title": "SNAP-8 (acetyl octapeptide-3)",
      "description": "SNAP-8 explained: a cosmetic wrinkle peptide related to Argireline, what the manufacturer's study showed, and why independent evidence is missing.",
      "url": "https://aminodesk.com/library/snap-8",
      "markdown_url": "https://aminodesk.com/library/snap-8.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/ss-31",
      "title": "SS-31 (elamipretide, Forzinity)",
      "description": "SS-31 explained: elamipretide's 2025 accelerated approval for Barth syndrome, its small trial, label dosing, and why it is not a proven longevity drug.",
      "url": "https://aminodesk.com/library/ss-31",
      "markdown_url": "https://aminodesk.com/library/ss-31.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/survodutide",
      "title": "Survodutide",
      "description": "Survodutide explained: Boehringer Ingelheim's weekly GLP-1 and glucagon injection, its 2026 Phase 3 results and side effects, and its US status.",
      "url": "https://aminodesk.com/library/survodutide",
      "markdown_url": "https://aminodesk.com/library/survodutide.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/tb-500",
      "title": "TB-500",
      "description": "TB-500 explained: what it is, why the human research belongs to a different molecule, its legal status, and where reported doses come from.",
      "url": "https://aminodesk.com/library/tb-500",
      "markdown_url": "https://aminodesk.com/library/tb-500.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/tesamorelin",
      "title": "Tesamorelin (Egrifta)",
      "description": "Tesamorelin explained: the FDA-approved growth-hormone-releasing drug for abdominal fat in HIV, its trial results, dosing and side effects.",
      "url": "https://aminodesk.com/library/tesamorelin",
      "markdown_url": "https://aminodesk.com/library/tesamorelin.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/tesamorelin-ipamorelin",
      "title": "Tesamorelin + ipamorelin blend",
      "description": "Tesamorelin + ipamorelin blend explained: what is in the blend, why no trial has tested it, and its legal position in the US.",
      "url": "https://aminodesk.com/library/tesamorelin-ipamorelin",
      "markdown_url": "https://aminodesk.com/library/tesamorelin-ipamorelin.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/tesofensine",
      "title": "Tesofensine",
      "description": "Tesofensine explained: an oral appetite drug, not a peptide, with a strong Phase 2 weight-loss result, a heart rate and blood pressure signal, and no FDA approval.",
      "url": "https://aminodesk.com/library/tesofensine",
      "markdown_url": "https://aminodesk.com/library/tesofensine.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/testosterone",
      "title": "Testosterone (cypionate, enanthate)",
      "description": "Testosterone explained: what it is approved for, the 2025 and 2026 label changes, the label dose for injections, blood pressure and fertility risks, and its controlled-substance status.",
      "url": "https://aminodesk.com/library/testosterone",
      "markdown_url": "https://aminodesk.com/library/testosterone.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/thymalin",
      "title": "Thymalin",
      "description": "Thymalin explained: a calf-thymus extract registered as an immune drug in Russia, the unblinded cohort behind its longevity claims, and why it has no US route.",
      "url": "https://aminodesk.com/library/thymalin",
      "markdown_url": "https://aminodesk.com/library/thymalin.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/thymogen",
      "title": "Thymogen (Glu-Trp)",
      "description": "Thymogen explained: a two-amino-acid immune drug registered in Russia since 1990, what its critics say about the evidence, and its status in the US.",
      "url": "https://aminodesk.com/library/thymogen",
      "markdown_url": "https://aminodesk.com/library/thymogen.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/thymosin-alpha-1",
      "title": "Thymosin alpha-1",
      "description": "Thymosin alpha-1 explained: an immune peptide approved abroad as Zadaxin for hepatitis B, its dosing there, and why it has no lawful US route.",
      "url": "https://aminodesk.com/library/thymosin-alpha-1",
      "markdown_url": "https://aminodesk.com/library/thymosin-alpha-1.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/thymulin",
      "title": "Thymulin",
      "description": "Thymulin explained: a zinc-dependent hormone made by the thymus, what human studies of zinc deficiency show, and why the injected peptide is untested.",
      "url": "https://aminodesk.com/library/thymulin",
      "markdown_url": "https://aminodesk.com/library/thymulin.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/tirzepatide",
      "title": "Tirzepatide (Zepbound, Mounjaro)",
      "description": "Tirzepatide explained: what it is, what trials found, the FDA label dosing schedule, side effects and self-pay cost.",
      "url": "https://aminodesk.com/library/tirzepatide",
      "markdown_url": "https://aminodesk.com/library/tirzepatide.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/tirzepatide-bpc-157",
      "title": "Tirzepatide + BPC-157 blend",
      "description": "Tirzepatide + BPC-157 blend explained: what is in the blend, why no trial has tested it, and its legal position in the US.",
      "url": "https://aminodesk.com/library/tirzepatide-bpc-157",
      "markdown_url": "https://aminodesk.com/library/tirzepatide-bpc-157.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/vesugen",
      "title": "Vesugen",
      "description": "Vesugen explained: a Russian short peptide sold for blood vessel support, what evidence exists, and why it has no lawful route in the US.",
      "url": "https://aminodesk.com/library/vesugen",
      "markdown_url": "https://aminodesk.com/library/vesugen.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/vilon",
      "title": "Vilon (Lys-Glu)",
      "description": "Vilon explained: a Russian short peptide sold for immune support and anti-aging, what evidence exists, and why it has no lawful route in the US.",
      "url": "https://aminodesk.com/library/vilon",
      "markdown_url": "https://aminodesk.com/library/vilon.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/vip",
      "title": "VIP (vasoactive intestinal peptide, aviptadil)",
      "description": "VIP explained: a natural gut and lung peptide, the failed COVID-19 trials of aviptadil, the nasal spray used in mold-illness protocols, and its compounding status.",
      "url": "https://aminodesk.com/library/vip",
      "markdown_url": "https://aminodesk.com/library/vip.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/vitamin-b12",
      "title": "Vitamin B12 injections (cyanocobalamin)",
      "description": "B12 injections explained: what they are approved for, the label schedule for pernicious anemia, and why the label lists nothing for energy or weight loss.",
      "url": "https://aminodesk.com/library/vitamin-b12",
      "markdown_url": "https://aminodesk.com/library/vitamin-b12.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "library/wolverine-blend",
      "title": "Wolverine blend (BPC-157 + TB-500)",
      "description": "The Wolverine blend explained: BPC-157 and TB-500 in one vial, why the mixed vial falls outside the 2026 compounding policy, and the absence of any human trial.",
      "url": "https://aminodesk.com/library/wolverine-blend",
      "markdown_url": "https://aminodesk.com/library/wolverine-blend.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "privacy",
      "title": "Privacy policy",
      "description": "What information Amino Desk collects, how it is used, who processes it and how to have it removed.",
      "url": "https://aminodesk.com/privacy",
      "markdown_url": "https://aminodesk.com/privacy.md",
      "kind": "site",
      "updated": "2026-11-17"
    },
    {
      "slug": "providers",
      "title": "How to vet a provider",
      "description": "Five checks to run on any telehealth provider selling GLP-1s or peptides, the red flags, and what the FDA's warning letters reveal.",
      "url": "https://aminodesk.com/providers",
      "markdown_url": "https://aminodesk.com/providers.md",
      "kind": "health",
      "updated": "2026-11-17"
    },
    {
      "slug": "stacks",
      "title": "Blends and stacks",
      "description": "Wolverine, Glow, KLOW and the retatrutide weight-loss stacks: what is in each, the compounding rule that excludes mixed vials, and why no combination has been tested.",
      "url": "https://aminodesk.com/stacks",
      "markdown_url": "https://aminodesk.com/stacks.md",
      "kind": "health",
      "updated": "2026-11-15"
    },
    {
      "slug": "tracker",
      "title": "Regulation tracker",
      "description": "A dated timeline of FDA and HHS actions on peptides and GLP-1 medications in the United States, with a source on every entry.",
      "url": "https://aminodesk.com/tracker",
      "markdown_url": "https://aminodesk.com/tracker.md",
      "kind": "site",
      "updated": "2026-11-14"
    }
  ]
}